How would you manage a patient with brain metastases treated with FSRT that inadvertently continued Alectinib during treatment?

Topics: Radiation Oncology • Neuro-Oncology

Do you usually hold Alectinib before SRS/FSRT? If so how long and when do you resume? Any special screening/precautions for patient who received FSRT with concurrent alectinib?

Related Questions

What dose, constraints, and technical parameters would you use for a SIB FSRT plan for a large brain metastasis resection cavity with rapid interval tumor growth along periphery of the resection cavity?

How would you manage a radiation induced sarcoma of the spinal cord following R1 resection?

Do you ever perform adaptive replanning for interfraction tumor volume changes appreciated during a fractionated SRS ( 5 fx) treatment for CNS metastases?

For those rare patients now out 5 years post GBM treatment and continuous Optune, is there a point one would stop Optune?

What dose would you consider for a patient who received 59.4 Gy 18 years ago for a glioma of the right frontal lobe who is now S/P gross total resection for a high-grade glioma in the same area?

What is your approach to management of a subtotally resected pineal parenchymal tumor of intermediate differentiation (CNS WHO grade 2)?

In a young patient with recurrent low-grade glioma s/p gross total resection, is there any role for further observation instead of radiation and chemotherapy?

Do you treat an arteriovenous fistula with the same principles as an arteriovenous malformation?

Is whole brain radiation contraindicated for adults with Dandy Walker syndrome?

What approach do you use when treating adult diffuse gliomas with H3-G34 mutations, now classified into their own category under the 2021 glioma guidelines?